You are here: Home » PTI Stories » National » News
Business Standard

USFDA for voluntary action by Sun Pharma's on Halol plant observations

Press Trust of India  |  New Delhi 

US regulator USFDA has said it found objectionable conditions at Industries' plant in but did not recommend any action against the company.

The development led to a surge in the share price of the pharma major, which closed 8.13 per cent higher at Rs 528.20 on BSE.

In a notification on its website, the said it has issued Voluntary Action Indicated (VAI) status to the company's plant.

According to the USFDA, VAI means "Voluntary Action Indicated. Objectionable conditions were found but the problems do not justify further regulatory action..."

In February, the USFDA had issued three observations after inspecting the facility. The company had said it was preparing the response to the observations.

had received a warning letter from the USFDA over violation of manufacturing norms in its facility at in in end of 2015.

This follwed inspection of the facility in September 2014 by FDA inspectors.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, June 08 2018. 19:25 IST